These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7847630)

  • 1. Time-resolved immunofluorometric determination of specific mRNA sequences amplified by the polymerase chain reaction.
    Bortolin S; Christopoulos TK
    Anal Chem; 1994 Dec; 66(23):4302-7. PubMed ID: 7847630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of BCR-ABL transcripts from the Philadelphia translocation by hybridization in microtiter wells and time-resolved immunofluorometry.
    Bortolin S; Christopoulos TK
    Clin Chem; 1995 May; 41(5):693-9. PubMed ID: 7729047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-resolved fluorometric hybridization assays with RNA probes synthesized from polymerase chain reaction-generated DNA templates.
    Radovich P; Bortolin S; Christopoulos TK
    Anal Chem; 1995 Aug; 67(15):2644-9. PubMed ID: 8849029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prostate-specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry.
    Galvan B; Christopoulos TK; Diamandis EP
    Clin Chem; 1995 Dec; 41(12 Pt 1):1705-9. PubMed ID: 7497609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative RT-PCR combined with time-resolved fluorometry for determination of BCR-ABL mRNA.
    Bortolin S; Christopoulos TK
    Clin Chem; 1996 Dec; 42(12):1924-9. PubMed ID: 8969627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative reverse transcriptase-polymerase chain reaction for prostate-specific antigen mRNA.
    Galvan B; Christopoulos TK
    Clin Biochem; 1997 Jul; 30(5):391-7. PubMed ID: 9253515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemiluminescent microtiter method for detecting PCR amplified HIV-1 DNA.
    Suzuki K; Okamoto N; Watanabe S; Kano T
    J Virol Methods; 1992 Jul; 38(1):113-22. PubMed ID: 1644890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
    Furukawa Y; Ju SL; Cho HL; Tatsumi N
    Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Futaki M; Dan K; Nomura T
    Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorimetric detection for PCR amplified HIV-1 DNA using magnetic beads.
    Suzuki K; Okamoto N; Kano T
    J Virol Methods; 1993 Mar; 41(3):341-50. PubMed ID: 8473372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous detection of IFN-gamma and IL-4 mRNAs using RT-PCR and time-resolved fluorometry.
    Halminen M; Sjöroos M; Mäkelä MJ; Waris M; Terho E; Lövgren T; Ilonen J
    Cytokine; 1999 Jan; 11(1):87-93. PubMed ID: 10080884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates.
    Christopoulos TK; Diamandis EP
    Anal Chem; 1992 Feb; 64(4):342-6. PubMed ID: 1377456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative polymerase chain reaction using a recombinant DNA internal standard and time-resolved fluorometry.
    Bortolin S; Christopoulos TK; Verhaegen M
    Anal Chem; 1996 Mar; 68(5):834-40. PubMed ID: 8779442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random primer p(dN)6-digoxigenin labeling for quantitation of mRNA by Q-RT-PCR and ELISA.
    Lear W; McDonnel M; Kashyap S; Boer PH
    Biotechniques; 1995 Jan; 18(1):78-80, 82-3. PubMed ID: 7702858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enzyme-amplified time-resolved fluorescence detection for nucleic acid hybridization assays].
    Zhao QR; Li MJ; Liu J; Song NL; Chen A; Zhuang XL; Liu BC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):84-8. PubMed ID: 12905847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly sensitive and fast nonradioactive method for detection of polymerase chain reaction products.
    Holmstrøm K; Rossen L; Rasmussen OF
    Anal Biochem; 1993 Mar; 209(2):278-83. PubMed ID: 8470800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis.
    Martinelli G; Testoni N; Montefusco V; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazzi F; de Vivo A; Pane F; Rosti G; Tura S
    Haematologica; 1998 Jul; 83(7):593-601. PubMed ID: 9718863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-radioactive detection of the rearranged BCR/ABL sequences amplified by polymerase chain reaction.
    Lion T; Prischl F; Haas OA; Pont J; Schwarzmeier J
    Leukemia; 1991 Feb; 5(2):156-9. PubMed ID: 2020197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
    Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.